knowledge -WSS

knowledge

author：leisure time 2025-10-02 22:41:37 - browse：193

A person walks past the Palantir sign. -- health tech coverage from STAT — FABRICE COFFRINI/AFP via Getty Images

PALO ALTO, Calif. — At a bustling artificial intelligence conference in June hosted by data heavyweight Palantir, a handful of relative newcomers — hospital executives — milled among government and defense industry customers spiritedly trading new uses for the company’s automation and analytics services.

Palantir is best known for its work in government and intelligence, but early adopters of the company’s nascent health offerings, including leaders from Cleveland Clinic, Tampa General Hospital, and HCA, offered demos and gave keynotes last month explaining applications like sepsis monitoring or staff scheduling tools.

For the hospital systems, it’s an expensive bid to tailor the company’s AI technology to hospital operations — and an attempt to blunt the effects of severe staffing shortages and limited bed space amid a resurgence of in-person care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Food makers tried to stack nutrition panel with preferred experts

focus

WSS

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

PEPFAR is under serious threat — and so is global health

'A game

Regeneron agrees to White House price limits on anti

Covid’s new normal has set in amid another rise in cases

Information blocking fines are now fair game in health care

entertainment

knowledge

leisure time

What does generative AI mean for health care? We asked experts

How housing is health care on Long Island

At least 13 dead in Texas as scorching temps continue

How the messy conversation about Dolly changed bioethics

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

'A game

As demand for Covid shots wanes, Moderna seeks its next success

What to make of Biden’s latest efforts on cancer research

Moonlake's readout produced a cash windfall. Risks remain

Regeneron agrees to White House price limits on anti

explore

House panel takes first step toward fixing drug shortages

Fed up with FDA, ALS advocates consider a take

Hospitals consider fixing cancer drug shortages on their own

Acelyrin, a rare IPO success, stumbles in its first big test

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Medicare to pay more for cardiac rehab in hospital outpatient clinics

focus

hotspot

leisure time

Wikipedia